Banner University Medical Center Tucson

KATE FARMS APPOINTS PHYSICIAN AND REGISTERED DIETITIAN CHRISTINA J. VALENTINE TO CHIEF MEDICAL OFFICER POST

Retrieved on: 
Wednesday, November 8, 2023
Texas Children's Hospital, University, Conditional sentence, Medical Affairs Bureau, Preterm birth, Dicarboxylic acid, Pregnancy, Health, DHA, Food, Heart, Nationwide, Behavior, Ball State University, PubMed, Baylor College of Medicine, Banner University Medical Center Tucson, Medicine, Ohio State University, Probability, RDN, Hospital, FAAP, Cognition, MS, Nursing, Dietary supplement, Neonatology, Science, Pediatrics

SANTA BARBARA, Calif., Nov. 8, 2023 /PRNewswire/ -- Chairman and Chief Executive Officer of Kate Farms Brett Matthews announced today the company has named Dr. Christina J. Valentine as its new Chief Medical Officer.

Key Points: 
  • SANTA BARBARA, Calif., Nov. 8, 2023 /PRNewswire/ -- Chairman and Chief Executive Officer of Kate Farms Brett Matthews announced today the company has named Dr. Christina J. Valentine as its new Chief Medical Officer.
  • Dr. Valentine is responsible for developing the vision and strategy for the Science and Clinical division, in alignment with Kate Farms' overall business strategy.
  • Dr. Valentine most recently served as Chief Medical Officer, Medical Affairs at Reckitt/Mead Johnson Nutrition.
  • "Our Chief Medical Officer is a critically important role at Kate Farms, requiring a combination of medical nutrition, clinical research and commercial expertise," said Matthews.

New Data from Banner University Medicine Demonstrating Effectiveness of BVA-100® Use in Ambulatory Heart Failure Patients Presented at Heart Failure Society of America Annual Scientific Meeting

Retrieved on: 
Wednesday, October 11, 2023
Diagnosis, FCCP, MD, BVA, FACC, OH, Banner University Medical Center Tucson, Huntington Convention Center of Cleveland, FACP, Heart failure, Faculty, FAHA, Patient, Medical imaging

Oak Ridge, TN, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces new data from Banner University Medicine Advanced Heart Failure Clinic in Phoenix, AZ validating the benefits of the Company’s BVA-100 diagnostic blood test for ambulatory patients with advanced heart failure. Data were presented at the Annual Scientific Meeting of the Heart Failure Society of America (HFSA), which brought together the world’s leading experts in heart failure at the Huntington Convention Center in Cleveland, OH on October 8, 2023.

Key Points: 
  • Data were presented at the Annual Scientific Meeting of the Heart Failure Society of America (HFSA), which brought together the world’s leading experts in heart failure at the Huntington Convention Center in Cleveland, OH on October 8, 2023.
  • “The frequency of the variances in red blood cell volume tended to be greater and more severe than those found in total blood volume.
  • Silver, MD, FACP, FACC, FCCP, FAHA, FHFSA, principal investigator, and Faculty, Advanced Heart Failure Cardiologist at Banner University Medical Center.
  • Michael Feldschuh, Daxor’s CEO and President said, “Management of diuretic strategies remains one of the most difficult and challenging problems clinicians encounter in heart failure patients.

MemorialCare Appoints Todd Blake New Chief Operating Officer for Long Beach Medical Center and Miller Children's & Women's Hospital Long Beach

Retrieved on: 
Wednesday, August 9, 2023
Intermountain Medical Center, Banner Health, Intermountain Health, University, Bed, Long Beach Medical Center, Business, Public key certificate, National Association Medical Staff Services, Banner University Medical Center Tucson, ACHE, Growth, Health, Hospital, Trauma, Miller Children's Hospital, Nursing, Management

LONG BEACH, Calif., Aug. 9, 2023 /PRNewswire/ -- MemorialCare , a prominent nonprofit Southern California integrated health system, announced today that Todd Blake has been named the company's new Chief Operating Officer for Long Beach Medical Center and Miller Children's & Women's Hospital Long Beach .

Key Points: 
  • LONG BEACH, Calif., Aug. 9, 2023 /PRNewswire/ -- MemorialCare , a prominent nonprofit Southern California integrated health system, announced today that Todd Blake has been named the company's new Chief Operating Officer for Long Beach Medical Center and Miller Children's & Women's Hospital Long Beach .
  • As the new chief operating officer of MemorialCare's Long Beach Medical Center and Miller Children's & Women's Hospital Long Beach, Blake will be responsible for the planning, development, implementation and continuous improvement of the programs and services provided by Long Beach Medical Center and Miller Children's & Women's Hospital, while creating a synergistic and collaborative culture with the staff, management team and medical staff.
  • Prior to that position, Blake was chief operating officer at Banner Health where he oversaw hospital operations at its two hospital campuses in Tucson, AZ including Banner University Medical Center – Tucson and Banner University Medical Center - South.
  • "We are thrilled to have Todd join the executive leadership team at Long Beach Medical Center and Miller Children's.

Boston Scientific Receives FDA Approval for the POLARx™ Cryoablation System

Retrieved on: 
Tuesday, August 8, 2023
Heart, Freedom, Pulmonary vein stenosis, Boston Scientific, BSX, Anatomy, CE marking, Medicines and Healthcare products Regulatory Agency, Food and Drug Administration, FACC, Clinical trial, Cryoablation, Cryotherapy, Banner University Medical Center Tucson, Heart Rhythm, Patient, Freezing, Physician, PMDA, AF, FDA, NYSE, Food, Safety, Medical imaging, Medical device, FHRS, MD, Electrophysiology

MARLBOROUGH, Mass., Aug. 8, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the POLARx™ Cryoablation System. The new system, which is indicated for the treatment of patients with paroxysmal atrial fibrillation (AF), features the POLARx FIT Cryoablation Balloon Catheter, a device with the unique capability of enabling two balloon sizes – 28 and 31mm – in one catheter.

Key Points: 
  • First-of-its-kind expandable cryoballoon catheter advances cryoablation therapy, addresses key limitations with traditional systems
    MARLBOROUGH, Mass., Aug. 8, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the POLARx™ Cryoablation System.
  • "The U.S. approval of the POLARx Cryoablation System, which has been used in more than 25,000 patients worldwide to date, marks an exciting advancement for the treatment of AF and a new era of cryoablation capabilities," said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific.
  • The POLARx Cryoablation System received CE Mark in February of 2020 and Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approval in October of 2021.
  • The POLARx FIT catheter received approval in Europe, Japan, Canada and other Asia Pacific markets in 2023.

SK Biopharmaceuticals Assembles 'Board of Prominent Experts' to Boost Growth, Innovation

Retrieved on: 
Thursday, August 3, 2023
Epilepsy, SAB, Radiology, Clarivate, Mischer Neuroscience Institute, CGT, Therapy, Drug development, College, University, College of Medicine, American Epilepsy Society, NYU, United States Air Force Scientific Advisory Board, Innovation, Medicine, Research, Johns Hopkins School of Medicine, Banner University Medical Center Tucson, Bang, Epilepsy Foundation, Seoul National University, Internal medicine, Molecular imaging, FDA, Health, Stomach, Nanotechnology, Bibliometrics, Pharmaceutical industry, Neurology

SEOUL, South Korea, Aug. 2, 2023 /PRNewswire/ -- SK Biopharmaceuticals, a global biotech company, announced the formation of its Scientific Advisory Board (SAB), comprising of five prominent experts in oncology, epilepsy, and radiopharmaceutical therapy.

Key Points: 
  • ; and Il Minn, Ph.D., a radiopharmaceutical and theranostics expert; and Cheol-Young Maeng, Ph.D., a biopharmaceutical industry expert.
  • "The Board will work closely with SK Biopharmaceuticals to drive innovation, and further improve patient care and outcomes as the envisioned biotech company."
  • SK Biopharmaceuticals Chief Executive Officer Donghoon Lee said, "We believe the Board will provide SK Biopharmaceuticals profound insights to help the company make faster decision, transform, and navigate uncertainty.
  • He served as the CTO of SK Biopharmaceuticals in 2021.

Ramon W. Johnson, M.D., M.B.A, Becomes ABEM President

Retrieved on: 
Monday, July 24, 2023
Ohio State University, HealthPartners, Saint Anne, Denver Health Medical Center, Emergency medicine, University, Pediatrics, ABEM, Doctor, Professional, American Board of Emergency Medicine, Multimedia, University of Arizona College of Medicine – Tucson, Mel, Global Health, American Board of Commissioners for Foreign Missions, Regions Hospital, Banner University Medical Center Tucson, Public health, University of Colorado School of Medicine, Medical director, Patient, Division, Executive Committee, Mission Hospital (Mission Viejo, California), Hospital, S-1 Executive Committee, University of Connecticut School of Medicine, St. Anne's Hospital, Biostatistics, Management, Epidemiology

EAST LANSING, Mich., July 24, 2023 /PRNewswire/ -- Ramon W. Johnson, M.D., M.B.A., is the new President of the American Board of Emergency Medicine (ABEM).

Key Points: 
  • EAST LANSING, Mich., July 24, 2023 /PRNewswire/ -- Ramon W. Johnson, M.D., M.B.A., is the new President of the American Board of Emergency Medicine (ABEM).
  • "It is an incredible honor to represent ABEM as a community physician.
  • Continuing to set the highest standards for knowledge assessment and professionalism for all emergency physicians will benefit our patients and the specialty."
  • Dr. Kendall is Professor of Emergency Medicine and Vice Chair of Education at the University of Colorado School of Medicine.

HealthspanMD™ Launches Reverse AFib Program to Help Greater Phoenix Residents Treat and Manage the Potentially Deadly Condition

Retrieved on: 
Tuesday, July 18, 2023
Health, Telemedicine, Virtual Medicine, Other Health, Managed Care, General Health, Pharmaceutical, Cardiology, Blood pressure, Exercise, Hurst, Mayo Clinic, Centers for Disease Control and Prevention, Heart failure, Cholesterol, Stroke, Sleep, Weight loss, FACC, Risk, Medicare, Death, Banner University Medical Center Tucson, Dementia, Publication, MD, Arrhythmia, Medication, Liquor, Pharmaceutical industry, Nursing, Ventricular fibrillation, Atrial fibrillation

With deaths from AFib increasing steadily over the past two decades, more than 12 million Americans are expected to have AFib by 2030.

Key Points: 
  • With deaths from AFib increasing steadily over the past two decades, more than 12 million Americans are expected to have AFib by 2030.
  • “AFib is complex and challenging to treat,” said HealthspanMD Founder and board-certified cardiologist Robert Todd Hurst, MD, FACC, FASE.
  • However, Phoenix-based HealthspanMD has elevated these conventional treatments by introducing its Reverse AFib Program .
  • Enrollment in an ongoing, connected program with a team of experts to optimize the chance of reversing AFib.

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

Retrieved on: 
Friday, May 19, 2023
Field line, Heart failure, Arrest, Stroke, Medicine, Arrhythmia, Robotic magnetic navigation, Banner University Medical Center Tucson, US, Patient, Physician, Electrophysiology, Risk, Robotics, NYSE, US FDA, Safety, Medical device, Stereotaxis

ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’ Robotic Magnetic Navigation systems.

Key Points: 
  • ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’ Robotic Magnetic Navigation systems.
  • The combination of Abbott’s leading cardiac mapping system with Stereotaxis’ advanced robotic technology brings together highly detailed real-time diagnostic information with the unprecedented precision and stability of robotics during therapy delivery.
  • Technology integration enhances the physician experience, streamlines procedural workflow, and supports the improved treatment of patients with abnormal heart rhythms.
  • Stereotaxis and Abbott have successfully completed integration of their technologies and performed testing demonstrating joint compatibility.

New Phoenix Medical Practice Gets to Root of Chronic Diseases Contributing to Arizonans’ Leading Causes of Death

Retrieved on: 
Thursday, April 6, 2023
Managed Care, Men, General Health, Family, Consumer, Fitness & Nutrition, Health Insurance, Other Consumer, Cardiology, Women, Seniors, Health, Diabetes, Exercise, Insurance, Heart, Hurst, Mayo Clinic, Stroke, FACC, CDC, Blood, Hypertension, Medicare, Banner University Medical Center Tucson, Publication, Korea Disease Control and Prevention Agency, Death, Conditional sentence, Pharmaceutical industry, Nursing, MD

With the Centers for Disease Control and Prevention reporting 60% of Americans suffer from at least one chronic disease , prevention has never been more paramount.

Key Points: 
  • With the Centers for Disease Control and Prevention reporting 60% of Americans suffer from at least one chronic disease , prevention has never been more paramount.
  • “The Healthspan-10 focuses on the 10 most powerful factors for reducing and reversing the most common deadly diseases,” said Hurst.
  • The care team guides the patient through the program, addressing medical concerns, habit-building and accountability, among other key components.
  • He has more than 50 publications in peer-reviewed journals and has given more than 100 presentations at medical educational conferences.

Paige Announces Partnership with Sonora Quest Laboratories to Accelerate Precision Diagnostics for Patients Across Arizona

Retrieved on: 
Thursday, August 11, 2022
Technology, Mobile, Wireless, Health, Biometrics, Other Health, Oncology, Other Science, Research, General Health, Hospitals, Health Technology, Science, Data Management, Clinical Trials, FDA, Genomics, Laboratory, Biomarker, University, Banner University Medical Center Tucson, CEO, NYSE, Diagnosis, AI, Technology, College, Cancer, Research, Department, Health, Patient, Â, Professor, University of Arizona, Lab, Program, Partnership, Drug development, CAP, IVD, Pathology, DGX, Accreditation, Medical imaging, Medical device

The goal of the digital transformation project is to improve existing diagnostic workflows and accelerate precision diagnoses for patients across Arizona.

Key Points: 
  • The goal of the digital transformation project is to improve existing diagnostic workflows and accelerate precision diagnoses for patients across Arizona.
  • Under the partnership, Paige will provide Sonora Quest with the complete suite of Paiges AI-enabled digital pathology solutions, including the FullFocus viewer, Paige Prostate Detect and Paige Breast.
  • Sonora Quest Laboratories, a joint venture between Banner Health and Quest Diagnostics, is part of the nations largest integrated laboratory system with approximately 3,800 employees.
  • Sonora Quest Laboratories is the market share leader in clinical laboratory testing in Arizona, performing more than 97 million diagnostic tests per year.